Cellular Beauty Supplements

Jupiter Neurosciences Launched Nugevia GLO with Pharmaceutical Tech

Jupiter Neurosciences is bringing pharmaceutical precision to the beauty supplement game with 'Nugevia GLO,' a 'beauty-from-within' formula that works at the cellular level. The company combined their clinically validated Jotrol resveratrol delivery technology with NovaSol Astaxanthin, creating a two-capsule daily routine that targets skin hydration, cellular defense, and collagen integrity from the inside out.

This beauty supplement boasts pharmaceutical-grade bioavailability -- Jupiter leveraged their drug development platform to ensure the ingredients actually get where they need to go. The formula promises enhanced collagen synthesis, UV protection, better hydration, reduced pigmentation, and protection against oxidative stress and DNA damage. It's Jupiter's first move from prescription drugs into consumer wellness, tapping into the massive $8 trillion longevity market. Available this fall through direct-to-consumer channels, it's perfectly timed for the nutricosmetics boom expected to hit $8.5 billion by 2025.

Image Credit: adobe.stock/puhhha

Pharmaceutical-grade Supplements
Leveraging drug development technology in consumer supplements introduces enhanced bioavailability and effectiveness, setting a new standard for nutritional products.
Beauty-from-within Solutions
The integration of cellular-level beauty treatments into daily routines highlights a growing demand for supplements that support skin health from the inside.
Longevity Market Expansion
With the longevity market expanding, there is increasing interest in products that promise anti-aging benefits and overall cellular rejuvenation.

Who This Affects Most

Nutricosmetics
The nutricosmetics industry is on the rise as consumers seek dietary supplements that provide beauty benefits, reflecting a shift toward integrated wellness.
Direct-to-consumer Wellness
As companies bypass traditional retail channels, the direct-to-consumer wellness industry allows for closer relationships with consumers and personalized product offerings.
Biopharmaceuticals
Using pharmaceutical technologies for non-drug products unveils new opportunities in the biopharmaceutical industry to innovate beyond traditional medicine.
SCORE
6.7 out of 10
GENDER
50% Men50% Women
MARKETTop markets: North America
GENERATION
  • Gen Z
  • Gen Alpha
  • Millennial (primary audience)
  • Gen X (primary audience)
POPULARITY
Popularity 72%
Activity 75%
Freshness 55%

Solutions for innovators working at the edge of change. We help transform emerging ideas into practical, durable solutions by combining strategic thinking, creative exploration, and hands-on execution.

Trends © 2026 Trend Hunter Inc. All Rights Reserved.
LinkedIn Instagram X